Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity

被引:84
作者
Caux, Frederic
Plauchu, Henri
Chibon, Frederic
Faivre, Laurence
Fain, Olivier
Vabres, Pierre
Bonnet, Francoise
Ben Selma, Zied
Laroche, Liliane
Gerard, Marion
Longy, Michel
机构
[1] Univ Paris 13, Hop Avicenne & ERI 18, Serv Dermatol, Bobigny, France
[2] Hop Hotel Dieu, Serv Genet Clin, F-69288 Lyon, France
[3] Univ Bordeaux 2, Inst Bergonie, Lab Genet Mol, F-33076 Bordeaux, France
[4] Univ Bordeaux 2, EA 3669, Lab Genet Mol, F-33076 Bordeaux, France
[5] Hop Enfants, Ctr Genet, Dijon, France
[6] Hop Jean Verdier, Serv Med Interne, Bondy, France
[7] Hop Bocage, Serv Dermatol, Dijon, France
[8] Hop Robert Debre, Serv Genet Med, F-75019 Paris, France
关键词
Hamartoma syndrome; multiple; PTEN; proteus syndrome;
D O I
10.1038/sj.ejhg.5201823
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe two patients from distinct Cowden disease families with specific germline PTEN mutations whose disease differs from the usual appearance of Cowden disease. Their phenotype associates classical manifestations of Cowden disease and congenital dysmorphisms including segmental overgrowth, arteriovenous and lymphatic vascular malformations, lipomatosis and linear epidermal nevus reminiscent of the diagnosis of Proteus syndrome. We provide evidence in one of the two patients of a secondary molecular event: a loss of the PTEN wild-type allele, restricted to the atypical lesions that may explain an overgrowth of the affected tissues and the atypical phenotype. These data provide a new demonstration of the Happle hypothesis to explain some segmental exacerbation of autosomal-dominant disorders. They also show that a bi-allelic inactivation of PTEN can lead to developmental anomalies instead of malignant transformation, thus raising the question of the limitations of the tumor suppressive function in this gene. Finally, we suggest using the term 'SOLAMEN syndrome' (Segmental Overgrowth, Lipomatosis, Arteriovenous Malformation and Epidermal Nevus) in these peculiar situations to help the difficult distinction between the phenotype of our patients and Proteus syndrome.
引用
收藏
页码:767 / 773
页数:7
相关论文
共 27 条
  • [21] Germline mutation of the tumour suppressor PTEN in Proteus syndrome
    Smith, JM
    Kirk, EPE
    Theodosopoulos, G
    Marshall, GM
    Walker, J
    Rogers, M
    Field, M
    Brereton, JJ
    Marsh, DJ
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (12) : 937 - 940
  • [22] PTEN: from pathology to biology
    Sulis, ML
    Parsons, R
    [J]. TRENDS IN CELL BIOLOGY, 2003, 13 (09) : 478 - 483
  • [23] Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with proteus syndrome
    Thiffault, I
    Schwartz, CE
    Kaloustian, VD
    Foulkes, WD
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 130A (02) : 123 - 127
  • [24] Reassessment of the proteus syndrome literature: Application of diagnostic criteria to published cases
    Turner, JT
    Cohen, MM
    Biesecker, LG
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 130A (02) : 111 - 122
  • [25] Evolution of skin lesions in Proteus syndrome
    Twede, JV
    Turner, JT
    Biesecker, LG
    Darling, TN
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) : 834 - 838
  • [26] Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis
    Zhou, XP
    Marsh, DJ
    Hampel, H
    Mulliken, JB
    Gimm, O
    Eng, C
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (05) : 765 - 768
  • [27] Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes
    Zhou, XP
    Hampel, H
    Thiele, H
    Gorlin, RJ
    Hennekam, RCM
    Parisi, M
    Winter, RM
    Eng, C
    [J]. LANCET, 2001, 358 (9277) : 210 - 211